Fang Yang, Shunmei Li, Ruo Yuan & Yun Xiang. (2022) A bivalent aptamer and terminus-free siRNA junction nanostructure for targeted gene silencing in cancer cells. Journal of Materials Chemistry B 10:40, pages 8315-8321.
Crossref
Rajat Goyal, Hitesh Chopra, Inderbir singh, Kamal Dua & Rupesh K. Gautam. (2022) Insights on prospects of nano-siRNA based approaches in treatment of Cancer. Frontiers in Pharmacology 13.
Crossref
Kouta Tsubaki, Matthew L. Hammill, Andrew J. Varley, Mitsuru Kitamura, Tatsuo Okauchi & Jean-Paul Desaulniers. (2020) Synthesis and Evaluation of Neutral Phosphate Triester Backbone-Modified siRNAs. ACS Medicinal Chemistry Letters 11:7, pages 1457-1462.
Crossref
Debabrata Senapati, Bidhan Chandra Patra, Avijit Kar, Deep Sankar Chini, Soumendu Ghosh, Shinjan Patra & Manojit Bhattacharya. (2019) Promising approaches of small interfering RNAs (siRNAs) mediated cancer gene therapy. Gene 719, pages 144071.
Crossref
Fang Liu, Chunfang Wang, Yuantao Gao, Xiao Li, Feng Tian, Yongtao Zhang, Mingyang Fu, Pengfei Li, Yali Wang & Fei Wang. (2018) Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs. Molecular Diagnosis & Therapy 22:5, pages 551-569.
Crossref
Tamkin Ahmadzada, Glen Reid & David R. McKenzie. (2018) Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer. Biophysical Reviews 10:1, pages 69-86.
Crossref
Abdullah Al Hasan & A.T.M. Zafrul Azam. 2018. Design of Nanostructures for Theranostics Applications. Design of Nanostructures for Theranostics Applications
341
436
.
Dominika Jedrzejczyk, Edyta Gendaszewska-Darmach, Roza Pawlowska & Arkadiusz Chworos. (2017) Designing synthetic RNA for delivery by nanoparticles. Journal of Physics: Condensed Matter 29:12, pages 123001.
Crossref
Sook Hee Ku, Sung Duk Jo, Yeon Kyung Lee, Kwangmeyung Kim & Sun Hwa Kim. (2016) Chemical and structural modifications of RNAi therapeutics. Advanced Drug Delivery Reviews 104, pages 16-28.
Crossref
. 2016. Nanotechnology and Drug Delivery, Volume Two. Nanotechnology and Drug Delivery, Volume Two
383
415
.
Yang Liu & Jun Wang. 2016. The Long and Short Non-coding RNAs in Cancer Biology. The Long and Short Non-coding RNAs in Cancer Biology
429
458
.
Gulnihal Ozcan, Bulent Ozpolat, Robert L. Coleman, Anil K. Sood & Gabriel Lopez-Berestein. (2015) Preclinical and clinical development of siRNA-based therapeutics. Advanced Drug Delivery Reviews 87, pages 108-119.
Crossref
Tiejun LiMeihua WuYork Yuanyuan ZhuJianxin ChenLi Chen. (2014) Development of RNA Interference–Based Therapeutics and Application of Multi-Target Small Interfering RNAs. Nucleic Acid Therapeutics 24:4, pages 302-312.
Crossref
Jesper B. Bramsen, Arnold Grünweller, Roland K. Hartmann & Jørgen Kjems. 2014. Handbook of RNA Biochemistry. Handbook of RNA Biochemistry
1243
1278
.
. 2013. Epigenetics and Pathology. Epigenetics and Pathology
141
166
.
Philippe Monnier, Robin Vigouroux & Nardos Tassew. (2013) In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments. Antibodies 2:4, pages 193-208.
Crossref
Jung Seok KimYeon Kyung LeeHwa Yeon JeongSeong Jae KangMin Woo KimSeung Hyun RyuHong Sung KimKeun Sik KimDong-Eun KimYong Serk Park. (2013) Sendai F/HN Viroplexes for Efficient Transfection of Leukemic T Cells. Yonsei Medical Journal 54:5, pages 1149.
Crossref
Leyuan Xu, W. Andrew Yeudall & Hu Yang. 2013. Tailored Polymer Architectures for Pharmaceutical and Biomedical Applications. Tailored Polymer Architectures for Pharmaceutical and Biomedical Applications
197
213
.
Paolo Romania, Alice Bertaina, Giorgia Bracaglia, Franco Locatelli, Doriana Fruci & Rossella Rota. (2012) Epigenetic Deregulation of MicroRNAs in Rhabdomyosarcoma and Neuroblastoma and Translational Perspectives. International Journal of Molecular Sciences 13:12, pages 16554-16579.
Crossref
Murugan Ramalingam, Pekka Vallittu, Ugo Ripamonti & Wan-Ju LiYoon Cho, Murugan Ramalingam & Ziyad Haidar. 2012. Tissue Engineering and Regenerative Medicine. Tissue Engineering and Regenerative Medicine
473
498
.
Anastasios Dimou, Konstantinos N. Syrigos & Muhammad Wasif Saif. (2012) Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer. Therapeutic Advances in Medical Oncology 4:5, pages 271-279.
Crossref
Thomas Fröhlich, Daniel Edinger, Raphaela Kläger, Christina Troiber, Edith Salcher, Naresh Badgujar, Irene Martin, David Schaffert, Arzu Cengizeroglu, Philipp Hadwiger, Hans-Peter Vornlocher & Ernst Wagner. (2012) Structure–activity relationships of siRNA carriers based on sequence-defined oligo (ethane amino) amides. Journal of Controlled Release 160:3, pages 532-541.
Crossref
Garrett R Rettig & Mark A Behlke. (2012) Progress Toward In Vivo Use of siRNAs-II. Molecular Therapy 20:3, pages 483-512.
Crossref
Feng Yang, Chen Jin, Yongjian Jiang, Ji Li, Yang Di, Quanxing Ni & Deliang Fu. (2011) Liposome based delivery systems in pancreatic cancer treatment: From bench to bedside. Cancer Treatment Reviews 37:8, pages 633-642.
Crossref
Sarah J. Leung, Xenia M. Kachur, Michael C. Bobnick & Marek Romanowski. (2011) Wavelength-Selective Light-Induced Release from Plasmon Resonant Liposomes. Advanced Functional Materials 21:6, pages 1113-1121.
Crossref
Ralph A. Tripp & Stephen Mark Tompkins. 2011. RNA Interference. RNA Interference
272
305
.
Paul H. Johnson, Diane Frank, Kunyuan Cui, Roger Adami, Harry Wang, Michael Houston & Steven C. Quay. 2011. RNA Interference. RNA Interference
123
173
.
Rossella Rota, Roberta Ciarapica, Antonio Giordano, Lucio Miele & Franco Locatelli. (2011) MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality. Molecular Cancer 10:1, pages 120.
Crossref
Chad V. Pecot, George A. Calin, Robert L. Coleman, Gabriel Lopez-Berestein & Anil K. Sood. (2010) RNA interference in the clinic: challenges and future directions. Nature Reviews Cancer 11:1, pages 59-67.
Crossref
Jesper B. Bramsen & Jørgen Kjems. 2011. Antiviral RNAi. Antiviral RNAi
77
103
.
Xiaoming Chen, Hong Wen & Kinam Park. 2010. Oral Controlled Release Formulation Design and Drug Delivery. Oral Controlled Release Formulation Design and Drug Delivery
257
277
.
Emine ŞalvaLevent KabasakalFatih ErenFulya ÇakalağaoğluNaziye ÖzkanJülide Akbuğa. (2010) Chitosan/Short Hairpin RNA Complexes for Vascular Endothelial Growth Factor Suppression Invasive Breast Carcinoma. Oligonucleotides 20:4, pages 183-190.
Crossref
Jun Li & Zicai Liang. (2009) The Consideration of Synthetic Short Interfering RNA for Therapeutic Use. Basic & Clinical Pharmacology & Toxicology 106:1, pages 22-29.
Crossref
Edna M. Mora, Selanere L. Mangala, Gabriel Lopez-Berestein & Anil K. Sood. 2010. Gene-Based Therapies for Cancer. Gene-Based Therapies for Cancer
1
15
.
Jeffrey T. DeSano & Liang Xu. (2009) MicroRNA Regulation of Cancer Stem Cells and Therapeutic Implications. The AAPS Journal 11:4.
Crossref
Sang-Soo Kim, Himanshu Garg, Anjali Joshi & N. Manjunath. (2009) Strategies for targeted nonviral delivery of siRNAs in vivo. Trends in Molecular Medicine 15:11, pages 491-500.
Crossref
Yu-Kyoung Oh & Tae Gwan Park. (2009) siRNA delivery systems for cancer treatment. Advanced Drug Delivery Reviews 61:10, pages 850-862.
Crossref
M Mikhaylova, I Stasinopoulos, Y Kato, D Artemov & Z M Bhujwalla. (2008) Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA. Cancer Gene Therapy 16:3, pages 217-226.
Crossref
Yajaira SuárezWilliam C. Sessa. (2009) MicroRNAs As Novel Regulators of Angiogenesis. Circulation Research 104:4, pages 442-454.
Crossref
Mark A. Behlke. (2008)
Chemical Modification of siRNAs for
In Vivo
Use
. Oligonucleotides 18:4, pages 305-320.
Crossref
Priti Kumar, Hong-Seok Ban, Sang-Soo Kim, Haoquan Wu, Todd Pearson, Dale L. Greiner, Amale Laouar, Jiahong Yao, Viraga Haridas, Katsuyoshi Habiro, Yong-Guang Yang, Ji-Hoon Jeong, Kuen-Yong Lee, Yong-Hee Kim, Sung Wan Kim, Matthias Peipp, Georg H. Fey, N. Manjunath, Leonard D. Shultz, Sang-Kyung Lee & Premlata Shankar. (2008) T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice. Cell 134:4, pages 577-586.
Crossref
Birgit Spänkuch, Isabel Steinhauser, Heidrun Wartlick, Elisabeth Kurunci-Csacsko, Klaus I Strebhardt & Klaus Langer. (2008) Downregulation of Plk1 Expression By Receptor-Mediated Uptake of Antisense Oligonucleotide-Loaded Nanoparticles. Neoplasia 10:3, pages 223-234.
Crossref
Kathleen F. Pirollo & Esther H. Chang. (2008) Targeted Delivery of Small Interfering RNA: Approaching Effective Cancer Therapies. Cancer Research 68:5, pages 1247-1250.
Crossref
Yvonne Förster & Bernd Schwenzer. 2008. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
337
362
.
Achim Aigner. (2007) Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo. Applied Microbiology and Biotechnology 76:1, pages 9-21.
Crossref
Kathleen F. Pirollo, Antonina Rait, Qi Zhou, Sung Hee Hwang, John A. Dagata, Gerald Zon, Richard I. Hogrefe, Guillermo Palchik & Esther H. Chang. (2007) Materializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery System. Cancer Research 67:7, pages 2938-2943.
Crossref